England is on track to be one of the first countries in the world to eliminate the hepatitis C virus (HCV), thanks to a pioneering antiviral drugs programme. Since 2015, around 100,000 people have ...

Akiram Therapeutics, a Swedish clinical-stage biotech company specialising in molecular radiotherapy, and leading radiopharmaceutical biotech ITM Isotope Technologies Munich SE (ITM) have announced a ...

Veteran biotech figure Robert Langer has come up with a new venture, partnering with his daughter Susan on the launch of new gene-silencing player Soufflé Therapeutics. Watertown, Massachusetts-based ...

Jiangsu Hengrui Pharma's oral thrombopoietin (TPO) receptor agonist hetrombopag has been approved in China to treat low ...

Plump was appointed chief medical and scientific officer at Takeda in 2015, stepping up to the role of president three years later. Andy Plump, credited with a 'soup-to-nuts' overhaul of Takeda's R&D ...

AbbVie's Qulipta has become the first oral CGRP inhibitor to show efficacy in a phase 3 study involving women with menstrual ...

The National Commission into the Regulation of AI in Healthcare has delivered its keenly anticipated report, which gives ...

Right after reporting encouraging data with its Dravet syndrome gene therapy, Encoded Therapeutics has raised an impressive ...

There's no underplaying the seriousness of chronic obstructive pulmonary disease (COPD), the third leading cause of death worldwide, but a new study suggests laughter may be the right response.

US President Donald Trump has nominated White House health policy aide Heidi Overton to take up the mantle of commissioner for the Food and Drug Administration (FDA), ending months of speculation over ...

The Advanced Research Projects Agency for Health (ARPA-H) has awarded Siemens Healthineers up to $31.1 million over five years to accelerate the development of autonomous, remote, endovascular ...

Office of Management and Budget (OMB) Director Russell Vought. A move by the Trump administration to block new NIH research funding for external research teams, as well as some renewals, appears to ...